Lung Cancer Treatment: Keytruda Better Than Chemotherapy In Patients With Non-Small Cell Lung Cancer Clinical trial showed Merck's immune boosting drug Keytruda is better than chemotherapy in patients with lung cancer. Bristol-Myers' Opdivo, however, fared worse than the older chemotherapy. by Rhodi Lee
Healthy Living/Wellness Opdivo And Cometriq Drugs Proven More Effective Than Novartis' Afinitor As Advanced Kidney Cancer Treatment by Rhodi Lee
Healthy Living/Wellness Thomson Reuters Report Says Pharma Sales To Shoot Past $1 Trillion Mark by Ted Ranosa